Sickle Cell Disease Ongoing Global Clinical Trials Analysis and Outlook
Sickle Cell Disease ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Sickle Cell Disease disease clinical trials. The research work analyzes the ongoing Sickle Cell Disease clinical trial trends across countries and companies.
The report focuses on drugs and therapies being evaluated for Sickle Cell Disease treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.
Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Sickle Cell Disease clinical trials.
Scope of the Report-
The report focuses on drugs and therapies being evaluated for Sickle Cell Disease treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.
Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Sickle Cell Disease clinical trials.
Scope of the Report-
- Ongoing Sickle Cell Disease clinical trials across regions
- Trial information by Phase and Subjects recruited
- Trial information by status, type, sponsor type
- Drugs used for treatment of Sickle Cell Disease
- Both observational and interventional trials analyzed
- Leading companies and universities participating in Sickle Cell Disease clinical trials
- Track competition and design competitive advantages
- Identify right partners to associate with for further research
- Evaluate potential opportunities available in further clinical trials of the disease
- Formulate business development strategies through success rates of clinical trials
- Identify quick markets for recruiting subjects based on trials count by each market
1 TABLE OF CONTENTS
1.1 List of Figures
1.2 List of Tables
2 KEY FINDINGS, 2018
2.1 Snapshot
2.2 Overview of Sickle Cell Disease Trials
3 CLINICAL TRIALS TRENDS TO 2022
3.1 Ongoing Sickle Cell Disease Trials by Phase
3.2 Ongoing Sickle Cell Disease Trials by Type
3.3 Ongoing Sickle Cell Disease Trials by Recruitment Status
4 COUNTRY LEVEL ANALYSIS
4.1 Region wise Ongoing Sickle Cell Disease Trials
4.2 Top 10 Countries conducting Sickle Cell Disease Trials
4.3 Trials in Emerging and Developing Economies
5 COMPANY LEVEL ANALYSIS
5.1 Ongoing Sickle Cell Disease Trials by Sponsor Type
5.2 Sickle Cell Disease Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors
6 ENROLMENT TRENDS TO 2022
6.1 Subjects Recruited for Sickle Cell Disease Trials by year
6.2 Subjects Recruited for Sickle Cell Disease Trials by Phase
6.3 Subjects Recruited for Sickle Cell Disease Trials by Trial Type
6.4 Subjects Recruited for Sickle Cell Disease Trials by Recruitment Status
7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS
7.1 Ongoing Sickle Cell Disease Trials- Phase
7.2 Ongoing Sickle Cell Disease Trials- Phase
7.3 Ongoing Sickle Cell Disease Trials- Phase
7.4 Ongoing Sickle Cell Disease Trials- Phase
8 APPENDIX
8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology
1.1 List of Figures
1.2 List of Tables
2 KEY FINDINGS, 2018
2.1 Snapshot
2.2 Overview of Sickle Cell Disease Trials
3 CLINICAL TRIALS TRENDS TO 2022
3.1 Ongoing Sickle Cell Disease Trials by Phase
3.2 Ongoing Sickle Cell Disease Trials by Type
3.3 Ongoing Sickle Cell Disease Trials by Recruitment Status
4 COUNTRY LEVEL ANALYSIS
4.1 Region wise Ongoing Sickle Cell Disease Trials
4.2 Top 10 Countries conducting Sickle Cell Disease Trials
4.3 Trials in Emerging and Developing Economies
5 COMPANY LEVEL ANALYSIS
5.1 Ongoing Sickle Cell Disease Trials by Sponsor Type
5.2 Sickle Cell Disease Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors
6 ENROLMENT TRENDS TO 2022
6.1 Subjects Recruited for Sickle Cell Disease Trials by year
6.2 Subjects Recruited for Sickle Cell Disease Trials by Phase
6.3 Subjects Recruited for Sickle Cell Disease Trials by Trial Type
6.4 Subjects Recruited for Sickle Cell Disease Trials by Recruitment Status
7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS
7.1 Ongoing Sickle Cell Disease Trials- Phase
7.2 Ongoing Sickle Cell Disease Trials- Phase
7.3 Ongoing Sickle Cell Disease Trials- Phase
7.4 Ongoing Sickle Cell Disease Trials- Phase
8 APPENDIX
8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology
LIST OF FIGURES
Figure 1: Sickle Cell Disease- Clinical Trials by Country
Figure 2: Sickle Cell Disease- Clinical Trials by Phase of Development, 2018
Figure 3: Sickle Cell Disease- Clinical Trials by Status, 2018
Figure 4: Sickle Cell Disease- Clinical Trials by Type, 2018
Figure 5: Sickle Cell Disease- Clinical Trials Split by Region, 2000-2018
Figure 6: Sickle Cell Disease- Clinical Trials by Type of Economy, 2018
Figure 7: Sickle Cell Disease- Enrolment by Phase, 2018
Figure 8: Sickle Cell Disease- Enrolment by Trial Type, 2018
Figure 9: Sickle Cell Disease- Enrolment by Recruitment Status, 2018
Figure 10: Sickle Cell Disease- Clinical Trials by Sponsor Type, 2018
Figure 11: Sickle Cell Disease- Enrolment by Type of Sponsors
Figure 12: Sickle Cell Disease- Enrolment by Leading Sponsors
Figure 1: Sickle Cell Disease- Clinical Trials by Country
Figure 2: Sickle Cell Disease- Clinical Trials by Phase of Development, 2018
Figure 3: Sickle Cell Disease- Clinical Trials by Status, 2018
Figure 4: Sickle Cell Disease- Clinical Trials by Type, 2018
Figure 5: Sickle Cell Disease- Clinical Trials Split by Region, 2000-2018
Figure 6: Sickle Cell Disease- Clinical Trials by Type of Economy, 2018
Figure 7: Sickle Cell Disease- Enrolment by Phase, 2018
Figure 8: Sickle Cell Disease- Enrolment by Trial Type, 2018
Figure 9: Sickle Cell Disease- Enrolment by Recruitment Status, 2018
Figure 10: Sickle Cell Disease- Clinical Trials by Sponsor Type, 2018
Figure 11: Sickle Cell Disease- Enrolment by Type of Sponsors
Figure 12: Sickle Cell Disease- Enrolment by Leading Sponsors
LIST OF TABLES
Table 1: Sickle Cell Disease- Clinical Trials by Sponsor Type, 2018
Table 2: Sickle Cell Disease- Clinical Trials by Economy Type, 2018
Table 3: Sickle Cell Disease- Clinical Trials by Region, 2018
Table 4: Sickle Cell Disease- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Sickle Cell Disease- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Sickle Cell Disease- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Sickle Cell Disease- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Sickle Cell Disease- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Sickle Cell Disease- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 1: Sickle Cell Disease- Clinical Trials by Sponsor Type, 2018
Table 2: Sickle Cell Disease- Clinical Trials by Economy Type, 2018
Table 3: Sickle Cell Disease- Clinical Trials by Region, 2018
Table 4: Sickle Cell Disease- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Sickle Cell Disease- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Sickle Cell Disease- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Sickle Cell Disease- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Sickle Cell Disease- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Sickle Cell Disease- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
